JP2015526446A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015526446A5 JP2015526446A5 JP2015527590A JP2015527590A JP2015526446A5 JP 2015526446 A5 JP2015526446 A5 JP 2015526446A5 JP 2015527590 A JP2015527590 A JP 2015527590A JP 2015527590 A JP2015527590 A JP 2015527590A JP 2015526446 A5 JP2015526446 A5 JP 2015526446A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- peptide
- bind
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 21
- 210000000130 stem cell Anatomy 0.000 claims 14
- 206010028980 Neoplasm Diseases 0.000 claims 13
- 201000011510 cancer Diseases 0.000 claims 13
- 210000004027 cell Anatomy 0.000 claims 11
- 101001133056 Homo sapiens Mucin-1 Proteins 0.000 claims 4
- 102100034256 Mucin-1 Human genes 0.000 claims 4
- 150000001413 amino acids Chemical class 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims 4
- 230000005907 cancer growth Effects 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 230000009702 cancer cell proliferation Effects 0.000 claims 1
- 238000002512 chemotherapy Methods 0.000 claims 1
- 208000020832 chronic kidney disease Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 230000002062 proliferating effect Effects 0.000 claims 1
- 230000005855 radiation Effects 0.000 claims 1
- 230000000638 stimulation Effects 0.000 claims 1
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261683155P | 2012-08-14 | 2012-08-14 | |
| US61/683,155 | 2012-08-14 | ||
| US201261684654P | 2012-08-17 | 2012-08-17 | |
| US61/684,654 | 2012-08-17 | ||
| US201261693712P | 2012-08-27 | 2012-08-27 | |
| US61/693,712 | 2012-08-27 | ||
| USPCT/US2012/060684 | 2012-10-17 | ||
| PCT/US2012/060684 WO2013059373A2 (en) | 2011-10-17 | 2012-10-17 | Media for stem cell proliferation and induction |
| PCT/US2013/025981 WO2013123084A1 (en) | 2012-02-13 | 2013-02-13 | Method for detecting circulating fetal cells |
| USPCT/US2013/025981 | 2013-02-13 | ||
| US201361837560P | 2013-06-20 | 2013-06-20 | |
| US61/837,560 | 2013-06-20 | ||
| PCT/US2013/055015 WO2014028668A2 (en) | 2012-08-14 | 2013-08-14 | Stem cell enhancing therapeutics |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017238427A Division JP6757712B2 (ja) | 2012-08-14 | 2017-12-13 | 幹細胞増強治療法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015526446A JP2015526446A (ja) | 2015-09-10 |
| JP2015526446A5 true JP2015526446A5 (https=) | 2016-10-06 |
| JP6664219B2 JP6664219B2 (ja) | 2020-03-13 |
Family
ID=50101604
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015527590A Active JP6664219B2 (ja) | 2012-08-14 | 2013-08-14 | 幹細胞増強治療法 |
| JP2017238427A Active JP6757712B2 (ja) | 2012-08-14 | 2017-12-13 | 幹細胞増強治療法 |
| JP2020037396A Pending JP2020109101A (ja) | 2012-08-14 | 2020-03-05 | 幹細胞増強治療法 |
| JP2021181985A Pending JP2022025136A (ja) | 2012-08-14 | 2021-11-08 | 幹細胞増強治療法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017238427A Active JP6757712B2 (ja) | 2012-08-14 | 2017-12-13 | 幹細胞増強治療法 |
| JP2020037396A Pending JP2020109101A (ja) | 2012-08-14 | 2020-03-05 | 幹細胞増強治療法 |
| JP2021181985A Pending JP2022025136A (ja) | 2012-08-14 | 2021-11-08 | 幹細胞増強治療法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US9932407B2 (https=) |
| EP (1) | EP2885000A4 (https=) |
| JP (4) | JP6664219B2 (https=) |
| CN (3) | CN104717980A (https=) |
| AU (2) | AU2013302620B2 (https=) |
| CA (1) | CA2882222A1 (https=) |
| IL (1) | IL237228B (https=) |
| WO (1) | WO2014028668A2 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3130607B1 (en) * | 2008-10-06 | 2024-04-17 | Minerva Biotechnologies Corporation | Muc1* antibodies |
| AU2015243948B2 (en) | 2014-04-07 | 2020-10-15 | Minerva Biotechnologies Corporation | Anti-NME antibody |
| CN116199790A (zh) * | 2015-02-10 | 2023-06-02 | 米纳瓦生物技术公司 | 人源化抗MUCl*抗体 |
| KR102486507B1 (ko) * | 2016-04-08 | 2023-01-09 | 아이티아이 헬스, 인크. | 플렉틴-1 결합 항체 및 그의 용도 |
| US20210107989A1 (en) * | 2017-04-04 | 2021-04-15 | Corvus Pharmaceuticals, Inc. | Methods for treating cd73hi tumors |
| JP7379347B2 (ja) * | 2017-10-11 | 2023-11-14 | ジィールバイオ，インコーポレーテッド | プレクチン１結合抗体およびその使用 |
| CA3121624A1 (en) | 2018-12-06 | 2020-06-11 | Arthrosi Therapeutics, Inc. | Methods for treating or preventing gout or hyperuricemia |
| CN120484122A (zh) * | 2019-01-11 | 2025-08-15 | 米纳瓦生物技术公司 | 抗可变muc1*抗体及其用途 |
| EP3920693A4 (en) | 2019-02-04 | 2022-10-05 | Minerva Biotechnologies Corporation | ANTI-NME ANTIBODIES AND METHODS OF TREATMENT OF CANCER OR CANCER METASTASIS |
| EP4161970A4 (en) | 2020-06-08 | 2024-07-10 | Minerva Biotechnologies Corporation | ANTI-NME ANTIBODIES AND METHODS FOR TREATING CANCER OR CANCER METASTASES |
| CA3183682A1 (en) | 2020-06-26 | 2021-12-30 | Minerva Biotechnologies Corporation | Anti-nme antibody and method of treating cancer or cancer metastasis |
| CN119317447A (zh) | 2022-04-12 | 2025-01-14 | 米纳瓦生物技术公司 | 抗可变muc1*抗体及其用途 |
| US20240261406A1 (en) | 2023-02-02 | 2024-08-08 | Minerva Biotechnologies Corporation | Chimeric antigen receptor compositions and methods for treating muc1* diseases |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2069439A1 (en) * | 1989-12-15 | 1991-06-16 | Susumu Iwasa | Monoclonal antibodies, their production and use |
| US5342947A (en) * | 1992-10-09 | 1994-08-30 | Glaxo Inc. | Preparation of water soluble camptothecin derivatives |
| JP2005508839A (ja) * | 2001-03-29 | 2005-04-07 | ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド | ペプチドおよびｍｕｃ１タンパク質に対する抗体 |
| EP2329822A1 (en) * | 2001-09-05 | 2011-06-08 | Minerva Biotechnologies Corporation | Compositions and methods of treatment of cancer |
| WO2003089451A2 (en) * | 2002-04-22 | 2003-10-30 | Dyax Corporation | Antibodies specific for mucin polypeptide |
| CA2491017A1 (en) * | 2002-07-03 | 2004-01-15 | Immunogen, Inc. | Antibodies to non-shed muc1 and muc16, and uses thereof |
| EP2526957A3 (en) | 2005-03-30 | 2013-02-20 | Minerva Biotechnologies Corporation | Proliferation of MUC1 expressing cells |
| US7825092B2 (en) * | 2006-08-08 | 2010-11-02 | University Of South Florida | Dendroaspis natriuretic peptide for treatment of cancer |
| US20090075926A1 (en) | 2006-12-06 | 2009-03-19 | Bamdad Cynthia C | Method for identifying and manipulating cells |
| US20100104626A1 (en) * | 2007-02-16 | 2010-04-29 | Endocyte, Inc. | Methods and compositions for treating and diagnosing kidney disease |
| EP3130607B1 (en) * | 2008-10-06 | 2024-04-17 | Minerva Biotechnologies Corporation | Muc1* antibodies |
| CN102272290B (zh) * | 2008-10-09 | 2018-08-14 | 米纳瓦生物技术公司 | 用于在细胞中诱导多能性的方法 |
| CN102264765B (zh) * | 2008-10-28 | 2016-01-20 | 盐野义制药株式会社 | 抗muc1抗体 |
| US8628959B2 (en) * | 2009-05-23 | 2014-01-14 | Incube Labs, Llc | Methods for cancer treatment using stem cells |
| MX2011013385A (es) * | 2009-06-11 | 2012-05-29 | Minerva Biotechnologies Corp | Metodos para cultivar celulas madre y celulas progenitoras. |
| EP3228629A1 (en) * | 2010-06-16 | 2017-10-11 | Minerva Biotechnologies Corporation | Reprogramming cancer cells |
-
2013
- 2013-08-14 WO PCT/US2013/055015 patent/WO2014028668A2/en not_active Ceased
- 2013-08-14 CN CN201380053708.7A patent/CN104717980A/zh active Pending
- 2013-08-14 JP JP2015527590A patent/JP6664219B2/ja active Active
- 2013-08-14 CN CN202010192670.3A patent/CN111388664A/zh active Pending
- 2013-08-14 EP EP13829213.1A patent/EP2885000A4/en active Pending
- 2013-08-14 CA CA2882222A patent/CA2882222A1/en active Pending
- 2013-08-14 AU AU2013302620A patent/AU2013302620B2/en active Active
- 2013-08-14 CN CN201810110588.4A patent/CN108175856B/zh active Active
-
2015
- 2015-02-13 US US14/622,677 patent/US9932407B2/en active Active
- 2015-02-15 IL IL237228A patent/IL237228B/en active IP Right Grant
-
2016
- 2016-12-28 US US15/392,858 patent/US20170121406A1/en not_active Abandoned
-
2017
- 2017-12-13 JP JP2017238427A patent/JP6757712B2/ja active Active
-
2018
- 2018-08-24 AU AU2018220126A patent/AU2018220126B2/en active Active
-
2020
- 2020-03-05 JP JP2020037396A patent/JP2020109101A/ja active Pending
-
2021
- 2021-11-08 JP JP2021181985A patent/JP2022025136A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015526446A5 (https=) | ||
| Kawaguchi et al. | SYT‐SSX breakpoint peptide vaccines in patients with synovial sarcoma: A study from the J apanese M usculoskeletal O ncology G roup | |
| CA2807942C (en) | Erythrocyte-binding therapeutics | |
| Takahashi et al. | First clinical trial of cancer vaccine therapy with artificially synthesized helper/killer‐hybrid epitope long peptide of MAGE‐A4 cancer antigen | |
| JP2016519933A5 (https=) | ||
| JP2019516663A5 (https=) | ||
| JP2019519215A5 (https=) | ||
| EA202190587A2 (ru) | Новые пептиды и комбинации пептидов для применения в иммунотерапии гепатоклеточной карциномы (гкк) и других видов рака | |
| JP2010529026A5 (https=) | ||
| JP2019513005A5 (https=) | ||
| JP2020506690A5 (https=) | ||
| JP2017507936A5 (https=) | ||
| BR112016009402A2 (pt) | Peptídeo, linfócitos t citotóxicos (ltc) ativados, método para sua produção, anticorpo, receptor de células t, ácido nucleico, célula hospedeira, uso dos mesmos, kit, método para produzir uma vacina anticâncer personalizada para um paciente individual | |
| JP2019536426A5 (https=) | ||
| JP2012102122A5 (https=) | ||
| AU2012342117A8 (en) | Recombinant proteins and their therapeutic uses | |
| JP2015506961A5 (https=) | ||
| JP2019520038A5 (https=) | ||
| RU2019113989A (ru) | Лекарственное средство | |
| NZ601980A (en) | Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same | |
| Lin et al. | Induction of liver-specific intrahepatic myeloid cells aggregation expands CD8 T cell and inhibits growth of murine hepatoma | |
| MX2022002293A (es) | Péptidos recombinantes inmunotolerantes similares a la elastina y métodos de uso. | |
| JP2019531254A5 (https=) | ||
| JP2019520059A5 (https=) | ||
| EA202190572A1 (ru) | Иммунотерапия раковых заболеваний рестриктированными по a*01 пептидами и комбинациями пептидов и относящиеся к ней способы |